Table 3. Characteristics of patients with JEV and DENV infection identified in this study.
| Patient characteristics | JEV (n = 13)a | DENV (n = 177)b | |
|---|---|---|---|
| Demographic | |||
| Sex, male | 8 (62%) | 84 (48%) | |
| Age | 23 (4−72) | 24 (1−75) | |
| Duration of illness before admission, days | 4 (2−7) | 4 (2−7) | |
| Hematology | |||
| Lowest hemoglobin, g/dl | 13 (10−16) | 13 (9−17) | |
| Lowest leukocyte counts, 103/μl | 4 (2−5)c | 3 (1−8) | |
| Leukopenia (<4,000/μl) | 7 (54%)d | 144 (82%) | |
| Lowest thrombocyte counts, 103/μl | 94 (24−258) | 53 (0.03−508) | |
| Thrombocytopenia (<150,000/μl) | 9 (69%)e | 163 (92%) | |
| Highest hematocrit, % | 47 (33−89)f | 43 (6−164) | |
| Clinical symptoms | |||
| Malaise | 11 (85%) | 153 (86%) | |
| Nausea | 9 (69%) | 143 (81%) | |
| Loss of appetite | 7 (54%) | 125 (71%) | |
| Myalgia | 5 (39%) | 87 (49%) | |
| Headache | 4 (31%)g | 105 (59%) | |
| Hemorrhage | 3 (23%) | 28 (16%) | |
| Arthralgia | 2 (15%) | 71 (40%) | |
| Vomiting | 2 (15%) | 72 (41%) | |
| Cough | 1 (8%) | 15 (9%) | |
| Retro-orbital pain | 1 (8%) | 38 (22%) | |
| Rash | 0 (0%) | 11 (6%) | |
| Diarrhea | 0 (0%) | 4 (2%) | |
| Runny nose | 0 (0%) | 4 (2%) | |
| Neck stiffness | 0 (0%) | 1 (1%) | |
| Seizure | 0 (0%) | 0 (0%) | |
| Abdominal pain | 0 (0%) | 25 (14%) | |
| Altered mental status | 0 (0%) | 0 (0%) | |
| Paralysis | 0 (0%) | 0 (0%) | |
| Glasgow Coma Scale <15 | 0 (0%) | 0 (0%) | |
Data are presented as number of patients (%) or median (range).
aIncludes confirmed JEV (n = 5) and probable JEV (n = 8) infection.
bIncludes confirmed DENV-infected patients identified by detection of DENV NS1 antigen detection and/or RT-PCR as depicted in Fig 1.
cStatistically significant compared with DENV (P = 0.002).
dStatistically significant compared with DENV (P = 0.018).
eStatistically significant compared with DENV (P = 0.007).
fStatistically significant compared with DENV (P = 0.003).
gStatistically significant compared with DENV (P = 0.045).